Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Aug 11, 2026

3M Co (MMM)

A forensic read on 3M Co built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

D · Weak — demands caution

Forensic grade

Safe

Financial health

8.3

Distress distance

Clean

Earnings quality

Forensic signals

31.4

P / E (ttm)

69.1%

ROE

$93.7B

Market cap

1.73%

Dividend yield

1.5%

Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

3M Co earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 8.3, placing it in the Safe zone. 4 forensic signals were flagged in its latest SEC filings, led by shareholder returns.

What the filings flag

345% of FCF

FY2025

Shareholder returns. Returned $4.8B to shareholders (buybacks + dividends) in FY2025 — 345% of free cash flow. More than free cash flow generated — and beyond operating cash too, so the extra is coming from debt or cash reserves, which isn't sustainable indefinitely. Counting the $225M of stock-based comp paid out in shares on top of that, the combined claim on free cash flow is 361%.

11.8%

FY2025

Return on invested capital. Return on invested capital is 11.8% in the latest fiscal year and rising from 10% — a modest positive spread over its ~10% cost of capital — growth adds value, though not dramatically.

$271M

FY2022–FY2022

Goodwill impairments. Took $271M of goodwill writedowns across 1 year (FY2022 ($271M)) — about 5% of net income over the span. Writedowns mean past acquisitions underperformed what was paid for them.

-40%

FY2023→FY2024

Dividend — cut. The payout was CUT ~40% in FY2024 (from FY2023). It still returns some cash, but it is NOT the dependable, rising dividend an unbroken streak implies.

Key fundamentals

Latest Revenue$24.95B

Revenue Growth YoY+1.5%

Revenue CAGR (3yr)-1.6%

Net Margin13.0%

Free Cash Flow$1.40B

Return on Equity69.1%

Debt / Equity2.68x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from 3M Co's actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Aug 11, 2026. Forensic signals flag probability, not certainty.